157 related articles for article (PubMed ID: 23592225)
21. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.
Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z
World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645
[TBL] [Abstract][Full Text] [Related]
22. HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway.
Han Y; Song C; Wang J; Tang H; Peng Z; Lu S
Mol Carcinog; 2018 Jun; 57(6):722-734. PubMed ID: 29436749
[TBL] [Abstract][Full Text] [Related]
23. Coexpression of ANXA2, SOD2 and HOXA13 predicts poor prognosis of esophageal squamous cell carcinoma.
Ma RL; Shen LY; Chen KN
Oncol Rep; 2014 May; 31(5):2157-64. PubMed ID: 24626613
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.
Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL
World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092
[TBL] [Abstract][Full Text] [Related]
25. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M
J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
[TBL] [Abstract][Full Text] [Related]
26. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
27. High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.
Ye F; Jin P; Cai X; Cai P; Cai H
Med Sci Monit; 2017 Dec; 23():6033-6041. PubMed ID: 29263314
[TBL] [Abstract][Full Text] [Related]
28. HOXA13 upregulation in gastric cancer is associated with enhanced cancer cell invasion and epithelial-to-mesenchymal transition.
He YX; Song XH; Zhao ZY; Zhao H
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):258-265. PubMed ID: 28165563
[TBL] [Abstract][Full Text] [Related]
29. Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma.
Liu L; Xu X; Jing L; Zhou G; Cao Z; Han Y; Zhou R
PLoS One; 2015; 10(2):e0118026. PubMed ID: 25689860
[TBL] [Abstract][Full Text] [Related]
30. Dickkopf-1 expression is a novel prognostic marker for gastric cancer.
Gao C; Xie R; Ren C; Yang X
J Biomed Biotechnol; 2012; 2012():804592. PubMed ID: 22496615
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of homeobox gene Barx2 increases gastric cancer proliferation and metastasis and predicts poor patient outcomes.
Mi Y; Zhao S; Zhou C; Weng J; Li J; Wang Z; Sun H; Tang H; Zhang X; Sun X; Peng Z; Wen Y
Oncotarget; 2016 Sep; 7(37):60593-60608. PubMed ID: 27533254
[TBL] [Abstract][Full Text] [Related]
32. HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways.
Duan R; Han L; Wang Q; Wei J; Chen L; Zhang J; Kang C; Wang L
Oncotarget; 2015 Sep; 6(29):27778-93. PubMed ID: 26356815
[TBL] [Abstract][Full Text] [Related]
33. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
34. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
36. High expression of long noncoding RNA Sox2ot is associated with the aggressive progression and poor outcome of gastric cancer.
Zou JH; Li CY; Bao J; Zheng GQ
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4482-4486. PubMed ID: 27874951
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value and clinical pathology of MACC-1 and c-MET expression in gastric carcinoma.
Ma J; Ma J; Meng Q; Zhao ZS; Xu WJ
Pathol Oncol Res; 2013 Oct; 19(4):821-32. PubMed ID: 23812675
[TBL] [Abstract][Full Text] [Related]
38. Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.
Jin X; Dai L; Ma Y; Wang J; Yan H; Jin Y; Zhu X; Liu Z
BMC Cancer; 2020 Sep; 20(1):866. PubMed ID: 32907552
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic value of
Wang MQ; Yin QY; Chen YR; Zhu SL
Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593
[TBL] [Abstract][Full Text] [Related]
40. The expression level of miR-203 in patients with gastric cancer and its clinical significance.
Zheng Y; Liu W; Guo L; Yang X
Pathol Res Pract; 2017 Dec; 213(12):1515-1518. PubMed ID: 29033185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
